SenesTech Inc. Raises $4.4 Million Through Warrant Exercise; Announces New Private Placement Warrants

Reuters
01 Jul
SenesTech Inc. Raises $4.4 Million Through Warrant Exercise; Announces New Private Placement Warrants

SenesTech Inc., a leader in fertility control for managing animal pest populations, has announced definitive agreements for the exercise of certain outstanding warrants to purchase a total of 1,458,872 shares of the company's common stock. Originally issued on March 11, 2025, these warrants have an exercise price of $2.90 per share. The transaction is expected to close around July 1, 2025, contingent on customary closing conditions. H.C. Wainwright is acting as the exclusive placement agent for this transaction. As part of the deal, SenesTech will issue new unregistered short-term warrants for up to 1,458,872 shares at an exercise price of $4.15 per share, with a purchase price of $0.125 per warrant in a private placement. These new warrants will be immediately exercisable and expire fifteen months after the effective date of the resale registration statement. The company anticipates gross proceeds of approximately $4.4 million from the existing warrant exercise, before fees and expenses, and potential gross proceeds of $6.0 million if the new warrants are fully exercised. The net proceeds will be used for working capital and general corporate purposes.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. SenesTech Inc. published the original content used to generate this news brief via PR Newswire (Ref. ID: LA21909) on July 01, 2025, and is solely responsible for the information contained therein.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10